JPM vs MRK: Which Is the Better Buy?

Side-by-side comparison of JPMorgan Chase & Co. and Merck & Co., Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-18.
JPMorgan Chase & Co. Β· Financial Services
$350.13
+26.9% upside to fair value
Med Conviction Grade A- High Quality
VS
Merck & Co., Inc. Β· Healthcare
$147.17
-4.1% upside to fair value
Med Conviction Grade C
QuantHub Verdict
JPM has more upside to fair value (+26.9%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric JPM MRK
Current Price $350.13 $147.17
Fair Value Estimate $444.48 $141.07
Upside to Fair Value +26.9% -4.1%
Market Cap $938.2B $363.5B
Forward P/E β€” β€”
EV / EBITDA 20.0x 29.6x
Price / Sales 3.1x 5.5x
Price / FCF β€” 22.6x
Revenue Growth YoY +17.9% +5.1%
Gross Margin 62.6% 75.4%
Operating Margin 28.2% 16.7%
Return on Equity 17.8% 6.6%
Dividend Yield 1.71% 2.31%
FCF Yield β€” 4.42%
Analyst Consensus Buy Buy
Investment Thesis
JPM β€” JPMorgan Chase & Co.
JPMorgan Chase is a diversified global bank spanning consumer banking, cards, payments, commercial banking, investment banking, markets, treasury services, and asset and wealth management, with an unusually high-quality franchise supported by funding scale, distribution, leading market positions and cross-selling across 86.6 million U.S. consumers and more than 90% of Fortune 500 companies. Busin…
MRK β€” Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
Accumulation Zones
Metric JPM MRK
Zone Low $333.36 $105.80
Zone High $377.81 $119.91
In Buy Zone? Yes No
← JPM Research    MRK Research β†’    All Research